Veloxis Pharmaceuticals
NC - CaryPharmaceutical
Focus: Veloxis Pharmaceuticals is a specialty pharmaceutical company focused on immunosuppression therapies, headquartered in Cary, NC with 5,000+ employees. The company generates 100% of revenue from ENVARSUS XR, a tacrolimus extended-release formulation for transplant patients.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Employees
5000+
Open Jobs
0
About Veloxis Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Veloxis Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
1 in 5yr
ENVARSUS XR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
LOE Approaching
Help build intelligence for Veloxis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.